Predictive validity of conversion from the clinical high risk syndrome to frank psychosis

• Published in: Schizophrenia research 2020-02, Vol.216, p.184-191
• Main Authors: Yoviene Sykes, Laura A., Ferrara, Maria, Addington, Jean, Bearden, Carrie E., Cadenhead, Kristin S., Cannon, Tyrone D., Cornblatt, Barbara A., Perkins, Diana O., Mathalon, Daniel H., Seidman, Larry J., Tsuang, Ming T., Walker, Elaine F., McGlashan, Thomas H., Woodberry, Kristen A., Powers, Albert R., Ponce, Allison N., Cahill, John D., Pollard, Jessica M., Srihari, Vinod H., Woods, Scott W.
• Format: Article
• Language: English
• Subjects: Humans; Longitudinal Studies; Predictive validity; Prodromal Symptoms; Psychotic Disorders - diagnosis; Psychotic Disorders - epidemiology; SIPS; Syndrome; Transition
• ISSN: 0920-9964; 1573-2509
• DOI: 10.1016/j.schres.2019.12.002

Although the clinical high risk for psychosis (CHR) paradigm has become well-established over the past two decades, one key component has received surprisingly little investigative attention: the predictive validity of the criteria for conversion or transition to frank psychosis. The current study evaluates the predictive validity of the transition to psychosis as measured by the Structured Interview for Psychosis-Risk Syndromes (SIPS) in CHR individuals. Participants included 33 SIPS converters and 399 CHR non-converters both from the North American Prodromal Longitudinal Study (NAPLS-2), as well as a sample of 67 separately ascertained first-episode psychosis (FEP) patients from the STEP program. Comparisons were made at baseline and one-year follow-up on demographic, diagnostic stability (SCID), and available measurement domains relating to severity of illness (psychotropic medication, psychosocial treatment, and resource utilization). Principal findings are: 1) a large majority of cases in both SIPS converters (n = 27/33, 81.8%) and FEP (n = 57/67, 85.1%) samples met criteria for continued psychosis at one-year follow-up; 2) follow-up prescription rates for current antipsychotic medication were higher in SIPS converters (n = 17/32, 53.1%) compared to SIPS non-converters (n = 81/397, 20.4%), and similar as compared to FEP cases (n = 39/65, 60%); and 3) at follow-up, SIPS converters had higher rates of resource utilization (psychiatric hospitalizations, day hospital admissions, and ER visits) than SIPS non-converters and were similar to FEP in most categories. The results suggest that the SIPS definition of psychosis onset carries substantial predictive validity. Limitations and future directions are discussed.